Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia. Is There Still a Role for Macrolide Therapy?

about

Epidemiology, virulence factors and management of the pneumococcus

P2860

Q28078832-DA84E9CF-DCBF-44F0-9298-C59D5FBC381E

P2860

Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia. Is There Still a Role for Macrolide Therapy?

Item

http://www.wikidata.org/entity/Q53840621

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Macrolide-Resistant Pneumococc ...... a Role for Macrolide Therapy?

@en

Macrolide-Resistant Pneumococc ...... a Role for Macrolide Therapy?

@nl

type

Item

label

Macrolide-Resistant Pneumococc ...... a Role for Macrolide Therapy?

@en

Macrolide-Resistant Pneumococc ...... a Role for Macrolide Therapy?

@nl

prefLabel

Macrolide-Resistant Pneumococc ...... a Role for Macrolide Therapy?

@en

Macrolide-Resistant Pneumococc ...... a Role for Macrolide Therapy?

@nl

P1476

Macrolide-Resistant Pneumococc ...... a Role for Macrolide Therapy?

@en

P2093

Michael S Niederman

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data.

Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis.

Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.

Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?).

β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.

The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia.

Antibiotic treatment strategies for community-acquired pneumonia in adults.

Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia

P304

1216-1217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1164/RCCM.201504-0701ED

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

191

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26029831

http://www.w3.org/2001/XMLSchema#string

P921

Bruschtfiewer

Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia. Is There Still a Role for Macrolide Therapy?

about

P2860

P2860

Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia. Is There Still a Role for Macrolide Therapy?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921